Insulet Corporation reports results for the quarter ended June 30 - Earnings Summary
Insulet Corporation reports results for the quarter ended June 30 - Earnings Summary
Insulet Corporation PODD.OQ reported quarterly adjusted earnings of $1.37 per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $1.17. The mean expectation of twenty three analysts for the quarter was for earnings of $1.45 per share. Wall Street expected results to range from $1.36 to $1.55 per share.
Revenue rose 23.5% to $801.70 million from a year ago; analysts expected $787.23 million.
Insulet Corporation's reported EPS for the quarter was $1.37.
The company reported quarterly net income of $95 million.
Insulet Corporation shares had risen by 9.6% this quarter and lost 41.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 0.6% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 22 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Insulet Corporation is $240.00, about 30.5% above its last closing price of $166.82
This summary was machine generated from LSEG data August 5 at 01:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 1.45 | 1.37 | Missed |
Mar. 31 2026 | 1.20 | 1.42 | Beat |
Dec. 31 2025 | 1.45 | 1.55 | Beat |
Sep. 30 2025 | 1.14 | 1.24 | Beat |